Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Blue Safari Group Acquisition Corp. (BSGA) Prices 5M Unit IPO at $10/Unit
-
Celsius Holdings Inc. (CELH) Prices 6.518M Share Common Offering at $62.50/Sh
-
Celsius Announces Pricing of Public Offering of Common Stock
-
Blue Safari Group Acquisition Corp. Announces Pricing of $50 Million Initial Public Offering
-
Atlanticus Holdings Corporation Prices $70 Million Offering of Series B Cumulative Perpetual Preferred Stock
-
Atlanticus Holdings Corporation Prices $70 Million Offering of Series B Cumulative Perpetual Preferred Stock
-
Atlanticus Hldgs (ATLC) to Offer Series B Cumulative Perpetual Preferred Stock
-
Atlanticus Holdings Corporation Announces Offering of Series B Cumulative Perpetual Preferred Stock
-
Atlanticus Holdings Corporation Announces Offering of Series B Cumulative Perpetual Preferred Stock
-
Ucommune International Ltd. Announces Unaudited First Quarter 2021 Financial Results
-
Orbsat Corp Announces Closing of Upsized $14.4 Million Public Offering
-
OceanTech Acquisitions I Corp. Announces Closing of $100.0 Million Initial Public Offering
-
Zivo Bioscience, Inc. Announces Closing of Upsized $13.8 Million Public Offering and Uplisting to Nasdaq
-
Zivo Bioscience, Inc. Announces Closing of Upsized $13.8 Million Public Offering and Uplisting to Nasdaq
-
Cognos Therapeutics Corp. Engages Maxim Group LLC for Investment Banking and Financial Advisory Services
-
Cognos Therapeutics Corp. Engages Maxim Group LLC for Investment Banking and Financial Advisory Services
-
Esports Entertainment Group (GMBL) Announces Private Placement of $35 Million Convertible Notes with $17.50 Conversion Price
-
Esports Entertainment Group Announces Private Placement of $35 Million Convertible Notes with $17.50 Conversion Price
-
Orbsat Corp. (OSAT) Prices 2.88M Unit Offering at $5/Unit; Announces Nasdaq Uplisting
-
Orbsat Corp Announces Pricing of Upsized $14.4 Million Underwritten Public Offering and Uplisting to Nasdaq
-
Zivo Bioscience Inc. (ZIVO) Prices 2.76M Unit Upsized Offering at $5/Unit; Announces Up-Listing to Nasdaq
-
OceanTech Acquisitions I Corp. (OTEC) Prices 10M Unit IPO at $10/Unit
-
Zivo Bioscience, Inc. Announces Pricing of Upsized $13.8 Million Public Offering and Up-listing to Nasdaq
-
Zivo Bioscience, Inc. Announces Pricing of Upsized $13.8 Million Public Offering and Up-listing to Nasdaq
-
OceanTech Acquisitions I Corp. Announces Pricing of $100.0 Million Initial Public Offering
-
Sphere 3D Corp. Announces Closing of $7.9 Million Public Offering and Partial Exercise of Overallotment Option
-
Annovis Bio, Inc. Announces Closing of $50 Million Public Offering
-
Reviva Pharmaceuticals (RVPH) Prices 8M Share Upsized $30M Share Common Offering
-
Reviva Announces Pricing of Upsized $30 Million Underwritten Public Offering
-
Sphere 3D (ANY) Prices 5.6M Share Common Offering at $1.25/Sh
-
Sphere 3D Corp. Announces Pricing of $7.0 Million Public Offering of Common Shares
-
INmune Bio, Inc. to Participate in Alzheimer Disease Panel Presented by Maxim Group LLC and hosted by M-Vest on May 26th, 2021
-
INmune Bio, Inc. to Participate in Alzheimer Disease Panel Presented by Maxim Group LLC and hosted by M-Vest on May 26th, 2021
-
Cassava Sciences to Participate in Q&A Panel Discussion on Alzheimer’s Disease
-
Cassava Sciences to Participate in Q&A Panel Discussion on Alzheimer’s Disease
-
Annovis Bio, Inc. Announces Pricing of Public Offering
-
Annovis Bio, Inc. Announces Proposed Public Offering of Common Stock
-
Annovis Bio to Participate in Alzheimer Disease Panel Presented by Maxim Group LLC and Hosted by M-Vest on May 26th, 2021
-
Cyclo Therapeutics to Participate in the M-Vest Virtual Conference Series: Alzheimer’s Disease Panel
-
UPDATE: Maxim Group Starts Clene, Inc. (CLNN) at Buy, $18 PT
-
Healthier Choices Management Corp. Announces Commencement of Rights Offering Subscription Period
-
Healthier Choices Management Corp. Announces Commencement of Rights Offering Subscription Period
-
Data Storage Corporation Announces Closing of Upsized $10.8 Million Public Offering
-
REEDS, Inc. (REED) PT Raised to $2 at Maxim Group, Following Earnings
-
5 Penny Stocks To Watch Right Now That Analysts Are Bullish On
-
CohBar Reports First Quarter 2021 Financial Results and Provides Business Update
-
CohBar Reports First Quarter 2021 Financial Results and Provides Business Update
-
Data Storage Corporation (DTST) Prices 1.6M Unit Upsized Offering at $6.75/Unit; Announces Uplisting to Nasdaq
-
Data Storage Corporation Announces Pricing of Upsized $10.8 Million Public Offering and Uplisting to Nasdaq
-
Galmed Pharmaceuticals (GLMD) PT Lowered to $6 at Maxim Group, Following Earnings

